Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytomegalovirus (CMV) encodes multiple envelope glycoproteins that assemble into distinct complexes on the viral surface. These complexes, including gB, gH/gL, gH/gL/gO, gH/gL/UL128-131, and gM/gN, are essential for viral entry, cell tropism, immune evasion, and pathogenesis. Targeting these complexes is a therapeutic strategy to prevent or treat CMV infections.
Viral entry inhibition
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytomegalovirus Glycoprotein Complexes (CMV Glycoprotein Complexes).